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SUMMARY 
Three newly established monoclonal hybridoma ntibodies to the aemagglutinin 
molecule of HVJ, designated A7, B3 and F 11, recognize operationally non-overlapping 
antigenic determinants and have neutralizing activity. Using these antibodies, the 
frequencies ofoccurrence of neutralization-resistant antigenic variants were analysed 
in virus populations released from four cell lines persistently infected with HVJ, 
namely GM2-HVJ, LLCMK2-HVJ, Vero-HVJ and GEsl-HVJ at various passage 
stages. Antigenic variants were selected from culture fluids of these HVJ carrier cells at 
a total frequency of 10 -3'3, 10 -3.8 and 10 -3.6 by monoclonal antibodies A7, B3 and 
F 11, respectively. These values were considerably higher than those of 10- ~.7 to 10-s-2 
detected in a stock preparation ofwild-type virus with these antibodies. All the variant 
viruses isolated as above were negative in neutralization, haemagglutination inhibition 
and immunofluorescent staining tests with each monoclonal antibody used for their 
isolation, but were positive with the other antibodies. 
Previous reports from this and other laboratories have shown that temperature-sensitive (ts) 
mutants, some of which contain altered M (membrane) or P (polymerase) proteins as well as 
protease activation mutants could be isolated from HVJ persistently infected cell lines 
demonstrating the selective advantage of these ts mutants in vitro over the original wild-type 
virus (Yoshida et al., 1979; Kimura et al., 1979; Ogura et al., 1981, 1982; Sato et al., 1981). 
Holland and co-workers, using vesicular stomatitis virus (VSV) have shown that genome 
changes can accumulate during persistent infection (Holland et al., 1979). Ter Meulen and co- 
workers have also demonstrated the occurrence of antigenic hanges detectable by monoclonal 
antibodies within the H polypeptide ofsubacute sclerosing panencephalitis (SSPE) virus during 
the course of a non-productive, persistent infection in vitro (ter Meulen et al., 1981). Monoclonal 
antibodies are highly specific reagents capable of detecting a single amino acid change in a 
determinant, and have been used to detect neutralization-resistant antigenic variants of HVJ, 
VSV and influenza A viruses spontaneously occurring at a frequency of approximately 10-s 
(Yewdell et al., 1979; Laver et al., 1979; Partner et al., 1980). Monoclonal antibodies against 
HVJ glycoproteins have recently been described by several groups (Yewdell & Gerhard, 1982; 
Partner, 1981; Orvell & Grandien, 1982). 
In the present study, we have used three monoclonal antibodies which recognize antigenic 
determinants that are operationally non-overlapping and have higher neutralizing capability, to 
estimate the frequency of variation in the antigenic determinants of the haemagglutinin (HN) 
molecule of HVJ during persistent infection in vitro. 
Hybridoma cell lines were produced by the methods of Gerhard et al. (1980). Cell lines 
secreting virus=specific antibodies were identified by indirect immunofluorescence staining 
with fluorescein-conjugated anti-mouse IgG (Miles Laboratories) on acetone-fixed HVJ- 
infected LLCMK2 cells in a micro-slide culture chamber (Bellco Glass, Inc). Antibody- 
secreting hybrids were cloned and grown in the peritoneal cavity of BALB/c mice to produce 
ascites. Monoclonal hybridoma ntibodies were initially screened for neutralizing activity 
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Table 1. Haemagglutination inhibiting (HI) and neutralization (NT) activity on monoclonal 
antibodies 
Monoclonal + Anti-mouse + Anti-mouse 
antibody HI* IgGserum NTf IgGserum 
A7 1280 1280 1000 1000 
B3 640 2560 2500 5000 
Fll 1280 2560 2500 5000 
* The HI test was performed by making twofold monoclonal antibody dilutions in microtitre plates and then 
adding 8 HA units of HVJ. After the mixture had been incubated for 30 rain at 4 °C, 25/~1 of anti-mouse IgG serum 
(1/20 dilution) (Fujizoki Corp., Japan) or PBS was added and incubated for a further 30 min, and then 50 ~tl of 
0.5% chicken erythrocytes was added. Maximum agglutination titres were reached after 1 h at 4 °C. Titres are 
expressed as the reciprocal of the highest twofold dilution causing complete inhibition of haemagglutination by 8 
HA units of virus. 
t NT tests were done by incubating HVJ with an infectivity titre of 100 p.f.u, with twofold serial dilutions of 
monoclonal antibodies at 4 °C for 2 h and a further 1 h in the presence or absence of anti-mouse IgG serum (2 ~tl). 
The remaining infectivities of the mixtures were assayed on LLCMK2 cells as described previously (Ogura et al., 
1981). 
against plaque-purified wild-type HVJ. After several cell fusion experiments, three out of 34 
hybridoma cell cultures ecreting antibodies against HVJ HN protein were selected which could 
neutralize a large amount of virus completely apart from residual neutralization-resistant 
antigenic variants. Antibody specificity was determined by radioimmunoprecipitation of 
[35S]methionine-labelled virus particles and SDS-polyacrylamide g l electrophoresis (Laemmli, 
1970). These three hybridoma antibodies precipitated only a single polypeptide with the 
expected mol. wt. of the HN (data not shown). 
The results of haemagglutination inhibition (HI) and neutralization (NT) tests using these 
monoclonal antibodies are shown in Table 1. The monoclonal antibodies A7, B3 and F l l  
effectively inhibited viral haemagglutinating activity and infectivity. The subsequent addition 
of anti-mouse IgG serum enhanced HI or NT titres of antibodies B3 and F 11 by two- to fourfold. 
The NT activity of these clones almost exceeded their HI activity. 
The frequency of neutralization-resistant igenic variants present in cloned HVJ wild-type 
was determined by comparison of the titre of virus treated with monoclonal antibody to the titre 
of untreated virus (5 x 106 p.f.u.). As shown in Table 2, the frequency of non-neutralized virus 
detected by antibody A7 was not greatly different at 5- to 25-, and at 5- to 125-fold ilution in the 
absence and presence of anti-mouse IgG serum, respectively. The monoclonal antibody B3 
neutralized effectively at 5-fold, and at 5- to 125-fold dilution in the absence and presence of 
anti-mouse IgG serum, respectively. Antibody F11 showed effective activity at fivefold dilution, 
with or without anti-mouse IgG serum. When non-neutralized viruses were examined by NT, 
HI and immunofluorescent staining tests, all the viruses isolated at the frequencies of less than 
10-4.7 were resistant to neutralization by the antibody used to isolate them but neutralized by the 
other antibodies; this suggests that antigenic determinants recognized by these three 
monoclonal antibodies were operationally non-overlapping. However, no variant viruses of this 
type were found among the viruses isolated at a frequency above 10- 3.7. These data indicate that 
the frequency of neutralization-resistant igenic variants in the wild-type stock virus was 
10 -4.7 to 10 -5.2 irrespective of which of the monoclonal antibodies was employed. 
Using these monoclonal antibodies, neutralization-resistant igenic variants were isolated 
from HVJ-carrying cells. Four carrier cultures, GM2 (from a 3-methylcholanthrene-induced 
fibrosarcoma of an inbred golden hamster)-HVJ, LLCMK2-HVJ,  Vero-HVJ and GEsl (from 
the embryo of an inbred golden hamster)-HVJ cells were recently established after infecting 
with wild-type HVJ purified by plaque isolation at 39 °C and maintained at 34 °C (Ogura et al., 
1981). Almost all of these carrier cells exhibited virus antigens, as judged by immunofluores- 
cence. The result of isolation of neutralization-resistant igenic variants from culture fluids of 
four HVJ-carrier cell lines at various passage stages are shown in Table 3. The frequencies of 
antigenic variants detected in these four carrier cells by monoclonal antibodies were not very 
different. A total of 59, 21 and 30 clones of variants were isolated from 1.3 x 105 p.f.u, of virus 
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Tab le  2. Frequency of neutralization-resistant tigenic variants from HVJ  wild-type stock 
detected by monoclonal antibodies* 
Frequency of 
Monoclonal Dilution non-neutralized + Anti-mouse 
antibody (-fold) viruses IgG serum 
A7 5 10 5.1 10-5q 
25 10 -4.7 10 -5.2 
125 >10 3.7 10 4.9 
625 > 10 3.7 >10 3.7 
B3 5 10 4.8 10 4.7 
25 > 10 -3.7 10 -4.8 
125 > 10 -3.7 10 -4.9 
625 > l0 3.7 • 10 3.7 
F l l  5 10 -4.8 10 -4.8 
25 > ]0 -3.7 > 10 -3.7 
* Neutralization-resistant antigenic variants were isolated from HVJ wild-type stock which had been purified 
through plaque isolation at 39 °C and grown in the egg allantoic avity. Fivefold serial dilutions of monoclonal 
antibodies (20 ktl) were mixed with 80 pl of HVJ with an infectivity titre of 5 × 106 p.f.u. After incubating the 
mixture for 16 h at 4 °C, 2 ~tl of anti-mouse IgG serum or Eagle's minimum essential medium was added and the 
mixture incubated further for 2 h at 4 °C. The infectivities of the mixtures were assayed on LLCMK2 cells as 
described previously (Ogura et al., 1981). 
Tab le  3. Isolation of neutralization-resistant tigenic variants from HVJ  carrier cells with 
monoc[onal antibodies* 
No. of variants isolated 
with antibody per 0.2 ml 
Passage Culture fluid c x • 
Cells no. p.f.u./0-2 ml A7 B3 F11 
GM2-HVJ 15 2.6 × 103 ND~ ND ND 
17 7.0 × 103 6 [ ND 
40 6.0 x l03 4 ND ND 
63 4'4 X 103 ND ND ND 
205 4.0 × 103 ND ND 2 
Vero-HVJ 5 1.8 x 10 ~ 1 ND ND 
10 < 10 1 ND ND 
t5 1"9 x 101 ND ND ND 
30 3"6 × l0 t 1 ND ND 
40 < 10 2 ND ND 
60 1.1 × l01 ND ND ND 
LLCMK2-HVJ 12 7.4 × 103 1 1 5 
20 8.2 × 104 35 17 11 
30 4.2 × 103 3 ND 1 
50 1.1 × 10 t 1 1 ND 
GEsl -HVJ  5 1.1 × 10 ~ ND 1 10 
10 1.4 x 103 ND ND ND 
15 2"2 × 102 1 ND ND 
20 2"4 × 101 ND ND ND 
50 < 10 2 ND 1 
Total 1.3 x 105 59 2t 30 
Average frequency 10 -3.3 10 -3.8 10 -3.s 
* Confluent monolayers of each carrier culture were maintained in MEM without calf serum at 34 °C for 24 h 
and culture fluids were harvested for the isolation of variant viruses. Viruses in the culture fluids were activated by 
incubating with 1 ~tg/ml of N-acetyl trypsin (Sigma) for 10min at room temperature and then 
phenylmethylsulphonyl fluoride (10 ~tg/ml; Sigma) was added to stop the trypsin action. An aliquot of 50 pl of 
monoclonal antibody was added to 0-2 ml of culture fluid pretreated with trypsin and incubated for 16 h at 4 °C. 
Non-neutralized virus was titrated on LLCMK2 cells after further incubation with anti-mouse IgG sera for 2 h. 
t ND, Not detected. 
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from HVJ-carrier cultures by selection with monoclonal antibodies A7, B3 and Fl l .  The 
frequencies calculated from the above data were  10 -3"3, 10 -3.8 and 10 -3"5, respectively. 
LLCMK2-HVJ cells at passage 20 produced about half the antigenic variants obtained in the 
present experiments. Antigenic variants elected from the culture fluid of LLCMK2-HVJ at 
passage 20 with antibodies A7, B3 and F11 occurred with a frequency of 10-3-4, 10-3.7 and 
10-3.9, respectively. Every isolated virus clone was examined by neutralization, haemagglutina- 
tion inhibition and immunofluorescent staining tests. No neutralization was observed with e 
monoclonal antibodies used for selection, whereas positive neutralization was observed with 
other antibodies (data not shown). The above frequencies were considerably higher than the 
frequencies of 10 -4.7 to 10 -5.2 detected in a stock preparation of HVJ wild-type. The 
frequencies of antigenic variants detected with monoclonal antibodies directed towards the 
haemagglutinin of HVJ or influenza A virus and the surface glycoprotein of VSV were of 
approximately the same order, namely 10- 5 for the three different viruses (Yewdell etal., 1979; 
Laver et al., 1979; Portner et al., 1980). Ter Meulen and co-workers reported that SSPE virus 
carrier cells became non-reactive with four out of six monoclonal antibodies against he H 
polypeptide of SSPE virus when tested by fluorescent antibody staining during the course of a 
non-productive, persistent infection in vitro (ter Meulen et al., 1981). However, they established 
SSPE virus persistent infection initially by intracerebral inoculation of hamsters with virus and 
then Veto cells were infected by co-cultivation with brain tissue from these animals. So, in their 
experiments, there is a possibility that spontaneously occurring mutant viruses were selected by 
the immune system. Schild et al. (1983) demonstrated host-cell selection of influenza virus 
antigenic variants. In our HVJ persistently infected cell lines, the appearance of antigenic 
variants was rather andom and, as is shown in Table 3, accumulation ofantigenic hanges was 
not observed. These results uggest that variations in these antigenic determinants did not lead 
to selective advantage of viruses during persistent infection in vitro. It is still unclear how and 
why genome changes or mutations leading to variations in antigenicity, cytopathogenicity, 
temperature s nsitivity and so on, some of which might seem to be advantageous, arise at higher 
frequencies during persistent i fection in vitro. Youngner et al., using VSV, reported that 
treatment of host cells with actinomycin D enhanced the frequency of occurrence of ts mutants, 
suggesting that a host cell factor(s) involved in the fidelity of RNA transcription might be 
repressed by the antibiotic, permitting many errors to be made (Youngner et al., 1981). In our 
preliminary experiments, attempts to enhance the frequency of antigenic variation by 
actinomycin D treatment and u.v.-irradiation of host cells were not successful. However, 
monoclonal antibodies are highly specific reagents capable of detecting a single amino acid 
change in a determinant (Laver et al., 1979) and their use may be a useful technique to elucidate 
the host cell factor(s) involved in virus variation during persistent infection in vitro. 
REFERENCES 
GERHARD, W., YEWDELL, J. W., FRANKEL, M., LOPES, D. & STAUDT, L. (1980), Monoclonal antibodies to influenza 
virus. In Monoclonal Antibodies, p. 317. Edited by K. Bechto, R. Kennet & T. McKearn. New York: Plenum 
press. 
HOLLAND, J. J., GRABAU, E. A., 3"ONES, C. L. & SEMLER, B. L. (1979). Evolution of multiple genome mutations during 
long-term persistent infection by vesicular stomatitis virus. Cell 16, 495-504. 
KIMURA, Y., ORVELL, C. & NORRBY, E. (1979). Characterization f the potypeptides synthesized in cells infected with 
a temperature-sensitive mutant derived from an HVJ (Sendal virus) carrier culture. Archives of Virology 61, 
23-33. 
LAEMMLI, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 
Nature, London 227, 680-685. 
LAVER, W. G., GERHARD, W., WEBSTER, R. G., FRANKEL, M. E. & AIR, G. M. (1979). Antigenic drift in type A influenza 
virus: peptide mapping and antigenic analysis of A/PR/8/34(HON1) variants selected with monoclonat 
antibodies. Proceedings ofthe National Academy of Sciences, U.S.A. 76, 1425-1429. 
OGURA, H., SATO, H. & HATANO, M. (1981). Temperature-sensitive HVJ (Sendal virus) with altered P polypeptide 
derived from persistently infected cell lines. Journal of General Virology 55, 469-473. 
OGURA, H., SATO, H. & HATANO, M. (1982). Development of protease activation mutants of HVJ (Sendal virus) in 
persistently infected cell cultures. Journal of General Virology 61, 207-215. 
6RVELL, C. & GRANDIEN, M. (1982). The effects of monoclonal antibody on biological activities of structural 
proteins of Sendai virus. Journal of Immunology 129, 2779 2787. 
Short communication 189 
PORTNER, A. (1981). The H N glycoprotein of Sendai virus: analysis of site(s) involved in hemagglutinating and 
neuraminidase activities. Virology 115, 375-384. 
PORTNER, g., WEBSTER, R. G. & BEAN, W. J. (1980). Similar frequencies of antigenic variants in Sendal, vesicular 
stomatitis, and influenza A viruses. Virology 104, 235-238. 
SATO, H., OGURA, n. & HATANO, M, (198 l). An intracellular interaction between a temperature-sensitive mutant and 
the original wild-type HVJ (Sendai virus) is responsible for the establishment and maintenance of HVJ 
persistent infection. Journal of General Virology 55, 459-468. 
SCHILD, G. C., OXFORD, J. S., DE JONG, J. C. & WEBSTER, R. G. (1983). Evidence for host-cell selection of influenza virus 
antigenic variants. Nature, London 303, 706-709. 
TER MEULEN, V., L6FFLER, S., CARTER, M. J. & STEPHENSON, J. R. (1981). Antigenic haracterization f measles and 
SSPE virus haemagglutinin by monoclonal antibodies. Journal of General Virilogy 57, 357-364. 
YEWDELL, J. W. & GERHARD, W. (1982). Delineation of four antigenic sites on a paramyxovirus glycoprotein via 
which monoclonal antibodies mediate distinct antiviral activities. Journal of Immunology 128, 2670-2675. 
YEWDELL, J. W., WEBSTER, R. G. & GERHARD, W. (1979). Antigenic variation in three distinct determinants of an 
influenza type A haemagglutinin molecule. Nature, London 279, 246. 
YOSHIDA, T., NAGAI, V., MAENO, K., IlNUMA, M., HAMAGUCHI, M., MATSUMOTO, T., NAGAYOSHI, S. & HOSHINO, M. (1979). 
Studies on the role of M protein in virus assembly using a ts mutant of HVJ (Sendai virus). Virology 92, 139 
154. 
YOUNGNER, J. S., JONES, E. V., KELLY, M. & FRIELLE, D. W. (1981). Generation and amplification of temperature- 
sensitive mutants during serial undiluted passages of vesicular stomatitis virus. Virology 108, 87-97. 
(Received 11 July 1983) 
